Joey Udovich's peptide therapy claims, fact-checked

What did @joeyudovich actually say?

The creator makes two core claims: first, that aging causes a drop in the body's natural peptide production, leaving us less able to heal and repair. Second, that peptide therapy is "regenerative and preventative care" that helps the body do "what it's actually designed to do, just better." She also emphasizes sourcing quality, stressing third-party testing and board-certified physicians.

To be fair, she keeps it accessible and avoids the most egregious hype you see in this space. She doesn't promise you'll lose 30 pounds or reverse Alzheimer's. But the claim that peptide therapy simply helps your body "remember how" to heal is doing a lot of work without a lot of specificity. That framing is catchy. It's also scientifically incomplete in ways that matter if you're actually considering therapy.

Does the science back this up?

Partially, yes. The basic biology is real. Peptides are short chains of amino acids and they do function as signaling molecules. Some of them genuinely decline with age. Growth hormone secretagogues like CJC-1295 and ipamorelin, for example, work because growth hormone pulsatility does decrease as we get older. The science on that mechanism is reasonably solid.

What's less solid is the leap from "peptides decline with age" to "peptide therapy restores youthful function." A 2019 review by Raun et al. in the journal Obesity noted that growth hormone secretagogues show real promise in clinical trials but that long-term safety data in healthy aging populations is still thin. GHK-Cu copper peptide has solid in vitro data on wound healing and collagen synthesis (Pickart and Margolina, 2018, Biomedicines), but human randomized controlled trial data is sparse. BPC-157 has compelling animal data. Human trials are limited and often industry-adjacent.

The body of evidence supports biological plausibility. It does not yet support broad clinical claims about "restoration."

What did they get wrong or right?

Right: the foundational biology. Peptides are endogenous signaling molecules and some do decline with physiological aging. Her sourcing advice, board-certified providers, third-party tested compounds, is genuinely important in a space with rampant gray-market products.

Wrong, or at least oversimplified: "the production of those amino acids drops" is a muddled sentence. Peptide production and amino acid availability are not the same thing. Amino acids come from diet. Specific signaling peptides decline due to hormonal and cellular aging mechanisms, not amino acid shortage in most healthy adults. That's a meaningful distinction the video glosses over.

Also worth flagging: the video's caption hashtags include MenopauseSupport, implying peptide therapy addresses menopausal symptoms. That's a significant extrapolation that the transcript doesn't actually support with evidence, and it points toward an audience who may be seeking alternatives to evidence-based hormone therapy. That framing deserves more scrutiny than the creator provides.

What should you actually know?

If you're curious about peptide therapy, here's what no Instagram video will tell you. Most peptides used in "optimization" contexts are not FDA-approved for anti-aging or recovery indications. Many are compounded medications, meaning the regulatory oversight differs substantially from approved drugs. Compounded peptides vary in purity and dosing accuracy across pharmacies.

The creator's advice to use board-certified physicians and third-party tested compounds is the floor, not a guarantee of safety or efficacy. You should also ask specifically which peptide, at what dose, for which indication, and what the monitoring protocol looks like. "Peptide therapy" is not one thing. BPC-157 and ipamorelin have completely different mechanisms, risk profiles, and evidence bases.

Cost is also worth naming. These protocols are rarely covered by insurance and can run hundreds of dollars monthly. "Don't just fall for the next good deal" is reasonable advice, but it doesn't mean the expensive option is automatically the right one either.